Lamotrigine Alone Compared to Lamotrigine Plus Antidepressant for the Treatment of Bipolar II Depression
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Bond, MD
University of British Columbia
Principal Investigator - Edwin Tam, MD
University of British Columbia
Study Director - Kyooseob Ha, Dr.
Seoul National University Bundang Hospital
Study Director - Lakshmi Yatham, MD
University of British Columbia
Study Director - Mauricio Kunz, Dr.
University of British Columbia
Study Director - Wetid Pratoomsri, Dr.
Chachoengsao Hospital Thailand
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of British Columbia Mood Disorders Centre
Vancouver, British Columbia, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2007
- Primary completion
- 30 Jun 2015
- Completion
- 30 Jun 2015
- Last update posted
- 4 Jun 2015
- Registered enrollment
- 15
- Registry id
- NCT00475137
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.